Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,121 | 1,205 | 98.5% |
| Education | $284.53 | 22 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,350 | 191 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,833 | 108 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,818 | 106 | $0 (2024) |
| Lilly USA, LLC | $1,178 | 83 | $0 (2024) |
| Novo Nordisk Inc | $1,041 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $959.14 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $907.76 | 60 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $769.45 | 50 | $0 (2024) |
| Amarin Pharma Inc. | $735.21 | 52 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $641.83 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,129 | 130 | Amgen Inc. ($315.55) |
| 2023 | $2,162 | 134 | Amgen Inc. ($362.38) |
| 2022 | $2,379 | 156 | Amgen Inc. ($385.59) |
| 2021 | $2,303 | 147 | Amgen Inc. ($340.01) |
| 2020 | $2,176 | 157 | Amgen Inc. ($284.51) |
| 2019 | $1,948 | 138 | GlaxoSmithKline, LLC. ($240.98) |
| 2018 | $2,828 | 190 | AstraZeneca Pharmaceuticals LP ($360.15) |
| 2017 | $2,481 | 175 | Janssen Pharmaceuticals, Inc ($302.98) |
All Payment Transactions
1,227 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.02 | General |
| Category: Opioid Analgesic | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.61 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Neurology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,153 | 2,284 | $293,808 | $145,291 |
| 2022 | 15 | 1,230 | 2,587 | $308,607 | $156,926 |
| 2021 | 17 | 1,401 | 2,770 | $359,108 | $171,511 |
| 2020 | 19 | 1,548 | 3,061 | $394,994 | $171,373 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 208 | 739 | $74,059 | $52,784 | 71.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 199 | 263 | $46,528 | $33,496 | 72.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 302 | $76,708 | $24,971 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 195 | $33,345 | $11,117 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 54 | 54 | $14,796 | $6,591 | 44.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 42 | 78 | $5,674 | $3,921 | 69.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $2,960 | $2,661 | 89.9% |
| 92548 | Test for balance and posture | Office | 2023 | 52 | 52 | $12,324 | $1,706 | 13.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 28 | 30 | $2,850 | $1,422 | 49.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 167 | $2,672 | $1,394 | 52.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $5,357 | $1,117 | 20.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,755 | $1,109 | 63.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 133 | 163 | $5,430 | $923.01 | 17.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 52 | 52 | $1,040 | $895.96 | 86.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 44 | 44 | $3,520 | $641.48 | 18.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 44 | 44 | $3,740 | $423.12 | 11.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $1,050 | $118.03 | 11.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 253 | 945 | $84,141 | $60,887 | 72.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 216 | 266 | $43,137 | $31,931 | 74.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 333 | $84,582 | $28,002 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 249 | $42,579 | $13,550 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $16,024 | $7,192 | 44.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 50 | 101 | $6,769 | $5,020 | 74.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 45 | $3,150 | $3,084 | 97.9% |
| 92548 | Test for balance and posture | Office | 2022 | 40 | 40 | $9,480 | $1,398 | 14.7% |
About Dr. Anton Daniel, MD
Dr. Anton Daniel, MD is a Internal Medicine healthcare provider based in Newport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700856135.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anton Daniel, MD has received a total of $18,405 in payments from pharmaceutical and medical device companies, with $2,129 received in 2024. These payments were reported across 1,227 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($18,121).
As a Medicare-enrolled provider, Daniel has provided services to 5,332 Medicare beneficiaries, totaling 10,702 services with total Medicare billing of $645,101. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Newport, TN
- Active Since 01/26/2006
- Last Updated 01/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700856135
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,132
- JARDIANCE (Drug) $1,011
- FARXIGA (Drug) $971.30
- Otezla (Drug) $951.19
- Vascepa (Drug) $735.21
- XARELTO (Drug) $713.63
- ELIQUIS (Drug) $683.15
- Ozempic (Drug) $669.27
- Aimovig (Biological) $623.16
- TRULICITY (Drug) $565.72
- REXULTI (Drug) $560.21
- SYMBICORT (Drug) $521.28
- XTAMPZA (Drug) $510.92
- VRAYLAR (Drug) $397.80
- Prolia (Biological) $352.82
- ANORO (Drug) $327.34
- NEXLETOL (Drug) $295.54
- EVENITY (Biological) $260.12
- Horizant (Drug) $259.42
- ENTRESTO (Drug) $248.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport
Candi Overholt, Md, MD
Internal Medicine — Payments: $18,838
Niva Khan, M.d, M.D
Internal Medicine — Payments: $6,286
Vijoydeep Tanjore Venkoba Rao, Md, MD
Internal Medicine — Payments: $5,723
Dr. Adrian Velasquez, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $5,261
Abby Lauer, Md, MD
Internal Medicine — Payments: $3,626
Nazmul Hoque, Md, MD
Internal Medicine — Payments: $2,851